Sky Vision Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.85 M
- Company Age 4 Year, 7 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 M
- Revenue Growth 67.74%
- Profit Growth -180.26%
- Ebitda -0.27%
- Net Worth 0.33%
- Total Assets -12.56%
About Sky Vision Pharma
Sky Vision Pharma Private Limited (SVPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 February 2021 (Four years 7 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.85 M.
The company currently has active open charges totaling ₹5.50 M.
Neha Arora, Isha Singh, and Damini Devlalikar serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239MP2021PTC071972
-
Company No.
120100
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Feb 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Sky Vision Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Arora
|
Director | 05-Apr-2021 | Current |
|
Isha Singh
|
Director | 07-Apr-2021 | Current |
|
Damini Devlalikar
|
Director | 05-Apr-2021 | Current |
Financial Performance of Sky Vision Pharma.
Sky Vision Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.74% increase. The company also saw a substantial fall in profitability, with a 180.26% decrease in profit. The company's net worth moved up by a moderate rise of 0.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sky Vision Pharma?
Unlock access to Sky Vision Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Metaheights Developers Private LimitedIsha Singh is a mutual person
-
Olyspo Olympus Private Limited
Isha Singh is a mutual person
Charges (Loans)
₹5.50 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2022 | State Bank Of India | ₹5.50 M | Open |
How Many Employees Work at Sky Vision Pharma?
Sky Vision Pharma has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sky Vision Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sky Vision Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
